BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 88 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,669,723 | -29.8% | 431,994 | -42.3% | 0.00% | -50.0% |
Q1 2024 | $3,803,874 | -38.1% | 748,794 | -27.0% | 0.00% | -33.3% |
Q4 2023 | $6,145,992 | +770.6% | 1,026,042 | +929.0% | 0.00% | – |
Q3 2023 | $705,954 | +12.4% | 99,711 | +11.8% | 0.00% | – |
Q2 2023 | $628,052 | -46.6% | 89,212 | -36.7% | 0.00% | -100.0% |
Q1 2023 | $1,175,573 | -6.1% | 140,956 | +29.3% | 0.00% | 0.0% |
Q4 2022 | $1,251,549 | +15.2% | 109,020 | +26.4% | 0.00% | 0.0% |
Q3 2022 | $1,086,000 | -0.5% | 86,235 | -16.4% | 0.00% | 0.0% |
Q2 2022 | $1,091,000 | -39.7% | 103,198 | -7.3% | 0.00% | 0.0% |
Q1 2022 | $1,809,000 | +7.4% | 111,287 | -8.5% | 0.00% | 0.0% |
Q4 2021 | $1,685,000 | -44.8% | 121,615 | -42.7% | 0.00% | 0.0% |
Q3 2021 | $3,050,000 | +35.9% | 212,199 | +49.5% | 0.00% | 0.0% |
Q2 2021 | $2,244,000 | +70.5% | 141,893 | +9.7% | 0.00% | 0.0% |
Q1 2021 | $1,316,000 | +23.5% | 129,321 | -9.6% | 0.00% | 0.0% |
Q4 2020 | $1,066,000 | +180.5% | 143,078 | +29.5% | 0.00% | – |
Q3 2020 | $380,000 | -26.6% | 110,495 | +1.5% | 0.00% | – |
Q2 2020 | $518,000 | -88.8% | 108,887 | -95.3% | 0.00% | -100.0% |
Q1 2020 | $4,641,000 | -64.6% | 2,320,459 | -39.0% | 0.00% | -55.6% |
Q4 2019 | $13,119,000 | +1137.6% | 3,803,254 | +926.2% | 0.01% | +800.0% |
Q3 2019 | $1,060,000 | +18.3% | 370,611 | +56.3% | 0.00% | 0.0% |
Q2 2019 | $896,000 | -55.9% | 237,089 | -5.2% | 0.00% | 0.0% |
Q1 2019 | $2,034,000 | +149.3% | 250,182 | +147.2% | 0.00% | 0.0% |
Q4 2018 | $816,000 | -89.4% | 101,210 | -90.0% | 0.00% | -50.0% |
Q3 2018 | $7,715,000 | +13.8% | 1,011,397 | -14.6% | 0.00% | 0.0% |
Q2 2018 | $6,782,000 | +54.5% | 1,183,712 | +28.6% | 0.00% | 0.0% |
Q1 2018 | $4,390,000 | +70.6% | 920,734 | +75.5% | 0.00% | 0.0% |
Q4 2017 | $2,573,000 | +93.2% | 524,666 | +106.1% | 0.00% | +100.0% |
Q3 2017 | $1,332,000 | -53.8% | 254,519 | -51.0% | 0.00% | -50.0% |
Q2 2017 | $2,886,000 | +53.7% | 519,304 | +132.2% | 0.00% | +100.0% |
Q1 2017 | $1,878,000 | -42.6% | 223,678 | -56.8% | 0.00% | -66.7% |
Q4 2016 | $3,273,000 | +43.5% | 517,529 | -0.0% | 0.00% | +50.0% |
Q3 2016 | $2,281,000 | +223.5% | 517,597 | +107.3% | 0.00% | – |
Q2 2016 | $705,000 | -13.7% | 249,725 | -13.8% | 0.00% | -100.0% |
Q1 2016 | $817,000 | -21.1% | 289,857 | +188.2% | 0.00% | 0.0% |
Q4 2015 | $1,035,000 | -32.8% | 100,565 | -25.7% | 0.00% | 0.0% |
Q3 2015 | $1,540,000 | +14.4% | 135,354 | +49.8% | 0.00% | 0.0% |
Q2 2015 | $1,346,000 | +295.9% | 90,361 | +138.6% | 0.00% | – |
Q1 2015 | $340,000 | +161.5% | 37,875 | +250.7% | 0.00% | – |
Q4 2014 | $130,000 | -67.5% | 10,800 | -73.8% | 0.00% | – |
Q3 2014 | $400,000 | +63.9% | 41,150 | +113.0% | 0.00% | – |
Q2 2014 | $244,000 | -75.2% | 19,316 | -79.3% | 0.00% | -100.0% |
Q1 2014 | $985,000 | +527.4% | 93,221 | +348.8% | 0.00% | – |
Q4 2013 | $157,000 | +3040.0% | 20,773 | +2867.6% | 0.00% | – |
Q3 2013 | $5,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |